Xenetic Biosciences Inc (NASDAQ:XBIO)’s share price was up 34.8% during mid-day trading on Friday . The stock traded as high as $4.10 and last traded at $3.33. Approximately 806,025 shares changed hands during trading, an increase of 176% from the average daily volume of 292,064 shares. The stock had previously closed at $2.47.

About Xenetic Biosciences (NASDAQ:XBIO)

Xenetic Biosciences, Inc, a clinical-stage biopharmaceutical company, focuses on the discovery, research, and development of next-generation biologic drugs and novel orphan oncology therapeutics. The company's lead investigational product candidate is oncology therapeutic XBIO-101 (sodium cridanimod) for the treatment of progesterone resistant endometrial cancer.

Recommended Story: Average Daily Trade Volume Explained

Receive News & Ratings for Xenetic Biosciences Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Xenetic Biosciences and related companies with MarketBeat.com's FREE daily email newsletter.